77
Registered trials
42
Recruiting
25
Completed trials
55
Sponsors
23
Countries
Phase III:
26
Phase II/III:
6
Phase II:
29
Phase I/II:
9
Phase III/IV:
1
Phase IV:
3
Phase I (Other):
1
Phase I (FiH):
2
Oversight events:
3 serious breaches
2 temporary halts
3 unexpected events
10 corrective measures
across 9 trials
View oversight register →
Indications tested
Colorectal cancer metastatic
5
Colorectal cancer
4
Non-small cell lung cancer
3
Adenocarcinoma gastric
2
Adenocarcinoma pancreas
2
Gastric cancer
1
Neuroendocrine carcinoma metastatic
1
Rectal cancer
1
Adenocarcinoma of colon
1
Carbohydrate antigen 19-9
1
Ductal adenocarcinoma of pancreas
1
Mesothelioma
1
Sponsors using this IMP
Merck Sharp & Dohme LLC
7
Fondazione GONO G.I.
5
Arcus Biosciences Inc.
3
Assistance Publique Hopitaux De Paris
3
Bristol-Myers Squibb Services Unlimited Company
3
Pfizer Inc.
3
Amgen Inc.
2
AstraZeneca AB
2
Centre Hospitalier Universitaire De Bordeaux
2
Unicancer
2
AbbVie Deutschland GmbH & Co. KG
1
Ability Pharmaceuticals S.A.
1
All trials — page 4
77 totalShowing 73–77 of 77 trials